NASDAQ: TECHBio Techne Revenue
Bio Techne revenue was $1.22B for the trailing 12 months ending Jun 30, 2025, with -56.1% growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $317.0M, up 0.2% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, TECH annual revenue was $1.2B, with 5.2% growth year-over-year.
TECH past revenue growth
How has TECH's revenue growth performed historically?
Company
5.23%
Industry
150.55%
Market
20.43%
TECH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TECH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TECH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
TECH revenue history
Current Revenue
$1.2B
Current Earnings
$73.4M
Current Profit Margin
6%
TECH's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when TECH announces revenue.
TECH Revenue History By Year
| TECH Yearly Revenue | TECH Revenue | TECH Change | TECH Revenue Growth |
|---|---|---|---|
| 2025-06-30 | $1.22B | $60.58M | +5.23% |
| 2024-06-30 | $1.16B | $22.36M | +1.97% |
| 2023-06-30 | $1.14B | $31.10M | +2.81% |
| 2022-06-30 | $1.11B | $174.57M | +18.75% |
| 2021-06-30 | $931.03M | $192.34M | +26.04% |
| 2020-06-30 | $738.69M | $24.69M | +3.46% |
| 2019-06-30 | $714.01M | $71.01M | +11.04% |
| 2018-06-30 | $642.99M | $79.99M | +14.21% |
| 2017-06-30 | $563.00M | $63.98M | +12.82% |
| 2016-06-30 | $499.02M | $46.78M | +10.34% |
| 2015-06-30 | $452.25M | $94.48M | +26.41% |
| 2014-06-30 | $357.76M | $47.19M | +15.19% |
| 2013-06-30 | $310.58M | -$3.99M | -1.27% |
| 2012-06-30 | $314.56M | $24.60M | +8.48% |
| 2011-06-30 | $289.96M | $20.92M | +7.77% |
| 2010-06-30 | $269.05M | $5.09M | +1.93% |
| 2009-06-30 | $263.96M | $6.54M | +2.54% |
| 2008-06-30 | $257.42M | $33.94M | +15.19% |
| 2007-06-30 | $223.48M | $20.87M | +10.30% |
| 2006-06-30 | $202.62M | $23.97M | +13.41% |
| 2005-06-30 | $178.65M | $17.40M | +10.79% |
| 2004-06-30 | $161.26M | $16.25M | +11.20% |
| 2003-06-30 | $145.01M | $14.11M | +10.78% |
| 2002-06-30 | $130.90M | $15.54M | +13.47% |
| 2001-06-30 | $115.36M | $11.52M | +11.09% |
| 2000-06-30 | $103.84M | $12.94M | +14.23% |
| 1999-06-30 | $90.90M | $23.61M | +35.09% |
| 1998-06-30 | $67.29M | $6.37M | +10.45% |
| 1997-06-30 | $60.92M | $6.33M | +11.60% |
| 1996-06-30 | $54.59M | $6.87M | +14.40% |
| 1995-06-30 | $47.72M | $7.39M | +18.32% |
| 1994-06-30 | $40.33M | $11.59M | +40.34% |
| 1993-06-30 | $28.74M | N/A | N/A |
Bio Techne Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.